Stelara
Showing 1 - 25 of 90
Psoriasis Trial in Australia, New Zealand (Stelara PFS)
Completed
- Psoriasis
- Stelara PFS
-
Brisbane, Australia
- +3 more
May 20, 2022
Plaque Psoriasis Trial in Hangzhou (BAT2206, Stelara (EU-sourced))
Active, not recruiting
- Plaque Psoriasis
- BAT2206
- Stelara (EU-sourced)
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Zhejiang University School of
Aug 18, 2022
Moderate to Severe Chronic Plaque Psoriasis Trial in Mayfield Heights (Stelara, Bmab1200)
Recruiting
- Moderate to Severe Chronic Plaque Psoriasis
- Stelara
- Bmab1200
-
Mayfield Heights, OhioApex Clinical Research Center
Jul 14, 2022
Crohn's Disease Trial in Chicago (Vedolizumab, Adalimumab, Ustekinumab)
Not yet recruiting
- Crohn's Disease
- Vedolizumab
- +2 more
-
Chicago, IllinoisUniversity of Chicago Medicine
Sep 13, 2023
Crohn Disease Trial in Ann Arbor (Low serine diet, High serine diet)
Recruiting
- Crohn Disease
- Low serine diet
- High serine diet
-
Ann Arbor, MichiganUniversity of Michigan
May 19, 2022
Psoriasis Trial in Tartu (CT-P43, Stelara)
Active, not recruiting
- Psoriasis
- CT-P43
- Stelara
-
Tartu, Tartu Country, Estonia, EstoniaClinical Research Centre
Jan 7, 2022
Moderate to Severe Chronic Plaque Psoriasis Trial in Norman, West Jordan (DMB-3115, Stelara)
Active, not recruiting
- Moderate to Severe Chronic Plaque Psoriasis
- DMB-3115
- Stelara
-
Norman, Oklahoma
- +1 more
Nov 28, 2021
Healthy Volunteers Trial in Melbourne (Stelara, RT-111 (0.5mg), RT-111 (0.75mg))
Not yet recruiting
- Healthy Volunteers
- Stelara
- +2 more
-
Melbourne, AustraliaNucleus Network
Jun 5, 2023
Inflammatory Disease, Autoimmune Diseases Trial in Paris (Kineret, Humira, Stelara)
Recruiting
- Inflammatory Disease
- Autoimmune Diseases
- Kineret
- +5 more
-
Paris, FranceHôpital Cochin
Oct 10, 2022
Psoriasis, Moderate to Severe Plaque Psoriasis Trial in Worldwide (Stelara® (Ustekinumab), SB17 (Proposed Ustekinumab
Active, not recruiting
- Psoriasis
- Moderate to Severe Plaque Psoriasis
- Stelara® (Ustekinumab)
- SB17 (Proposed Ustekinumab Biosimilar)
-
Brno, Czechia
- +32 more
Apr 13, 2022
Healthy Subjects Trial in Grafton, Christchurch (CT-P43, EU-approved Stelara, US-licensed Stelara)
Completed
- Healthy Subjects
- CT-P43
- +2 more
-
Grafton, Auckland, New Zealand
- +1 more
Aug 3, 2021
Plaque Psoriasis Trial in Worldwide (FYB202 (Proposed ustekinumab biosimilar), Stelara® (Ustekinumab))
Active, not recruiting
- Plaque Psoriasis
- FYB202 (Proposed ustekinumab biosimilar)
- Stelara® (Ustekinumab)
-
Tallinn, Estonia
- +15 more
Aug 5, 2021
Crohn Disease Trial in Ramat Gan (Crohn's disease exclusion diet (CDED), Ustekinumab Injection [Stelara])
Not yet recruiting
- Crohn Disease
- Crohn's disease exclusion diet (CDED)
- Ustekinumab Injection [Stelara]
-
Ramat Gan, IsraelSheba Medical Center
Feb 28, 2021
Psoriasis, Pregnancy, Psoriatic Arthritis Trial in La Jolla (Ustekinumab, Guselkumab)
Recruiting
- Psoriasis
- +3 more
-
La Jolla, CaliforniaUniversity of California, San Diego
Apr 1, 2021
Psoriatic Arthritis Trial in Frankfurt am Main (Methotrexate, Ustekinumab, Placebo)
Completed
- Psoriatic Arthritis
- Methotrexate
- +2 more
-
Frankfurt am Main, Hessia, GermanyCIRI
Mar 1, 2022
Uveitis Trial run by the NEI (Ustekinumab)
Completed
- Uveitis
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 4, 2021